123 related articles for article (PubMed ID: 7298264)
1. Effect of chronic sulpiride on striatal spiperone binding.
Bannet J; Gillis S; Ebstein RP; Belmaker RH
Int Pharmacopsychiatry; 1980; 15(6):334-7. PubMed ID: 7298264
[TBL] [Abstract][Full Text] [Related]
2. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
Jenner P; Rupniak NM; Marsden CD
Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
4. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
Köhler C; Haglund L; Ogren SO; Angeby T
J Neural Transm; 1981; 52(3):163-73. PubMed ID: 7198139
[TBL] [Abstract][Full Text] [Related]
5. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
Lazareno S; Nahorski SR
Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
[TBL] [Abstract][Full Text] [Related]
6. Chronic sulpiride increased 3H-spiperone binding and calmodulin dependent phosphorylation in rat striatum.
Lau YS; Runice C; Dowd FJ; Anene C
Proc West Pharmacol Soc; 1983; 26():139-43. PubMed ID: 6310625
[No Abstract] [Full Text] [Related]
7. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
8. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
Morgan DG; Sinha YN; Finch CE
Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
[TBL] [Abstract][Full Text] [Related]
9. Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol.
Bischoff S
Experientia; 1981; 37(9):1008-9. PubMed ID: 7297644
[TBL] [Abstract][Full Text] [Related]
10. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
Chivers JK; Reavill C; Jenner P; Marsden CD
J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
[TBL] [Abstract][Full Text] [Related]
11. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
Bhargava HN
Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397
[TBL] [Abstract][Full Text] [Related]
12. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
Köhler C; Ogren SO; Haglund L; Angeby T
Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
[TBL] [Abstract][Full Text] [Related]
13. Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.
Theodorou AE; Hall MD; Jenner P; Marsden CD
J Pharm Pharmacol; 1980 Jun; 32(6):441-4. PubMed ID: 6106685
[No Abstract] [Full Text] [Related]
14. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
[TBL] [Abstract][Full Text] [Related]
15. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration.
Owen F; Cross AJ; Waddington JL; Poulter M; Gamble SJ; Crow TJ
Life Sci; 1980 Jan; 26(1):55-9. PubMed ID: 7189005
[No Abstract] [Full Text] [Related]
16. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
Chiu S; Paulose CS; Mishra RK
Science; 1981 Dec; 214(4526):1261-2. PubMed ID: 6117947
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.
Howlett DR; Nahorski SR
Life Sci; 1980 Feb; 26(7):511-7. PubMed ID: 7366332
[No Abstract] [Full Text] [Related]
19. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Florijn WJ; Tarazi FI; Creese I
J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
[TBL] [Abstract][Full Text] [Related]
20. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
List SJ; Seeman P
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]